Mind Medicine (MindMed), Inc. (MNMD)
Total Valuation
MNMD has a market cap or net worth of $369.34 million. The enterprise value is $248.87 million.
| Market Cap | 369.34M |
| Enterprise Value | 248.87M |
Important Dates
The latest earnings date was Monday, May 16, 2022, before market open.
| Last Earnings Date | May 16, 2022 |
| Ex-Dividend Date | n/a |
Share Statistics
MNMD has 422.44 million shares outstanding. The number of shares has increased by 8.38% in one year.
| Shares Outstanding | 422.44M |
| Shares Change (YoY) | +8.38% |
| Shares Change (QoQ) | -0.03% |
| Owned by Insiders (%) | 12.49% |
| Owned by Institutions (%) | 12.92% |
| Float | 371.68M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 2.70 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | 11.67 |
| Quick Ratio | 11.41 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.00 |
| Debt / FCF | 0.00 |
Financial Efficiency
Return on equity (ROE) is -61.30%, which is considered low.
| Return on Equity (ROE) | -61.30% |
| Return on Assets (ROA) | -56.40% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.36M |
| Employee Count | 41 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -1.16M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -71.86% in the last 52 weeks. The beta is 1.77, so MNMD's price volatility has been higher than the market average.
| Beta (1Y) | 1.77 |
| 52-Week Price Change | -71.86% |
| 50-Day Moving Average | 0.84 |
| 200-Day Moving Average | 1.28 |
| Average Volume (30 Days) | 2,530,647 |
Short Selling Information
The latest short interest is 38.14 million, so 9.03% of the outstanding shares have been sold short.
| Short Interest | 38.14M |
| Short % of Shares Out | 9.03% |
| Short % of Float | 10.26% |
| Short Ratio (days to cover) | 13.77 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -97.42M |
| Pretax Income | -97.80M |
| Net Income | -96.64M |
| EBITDA | -95.20M |
| EBIT | -97.41M |
| Earnings Per Share (EPS) | -$0.23 |
Balance Sheet
The company has $120.47 million in cash and no debt, giving a net cash position of $120.47 million or $0.29 per share.
| Cash & Cash Equivalents | 120.47M |
| Total Debt | 0 |
| Net Cash | 120.47M |
| Net Cash Per Share | $0.29 |
| Book Value | 136.81M |
| Book Value Per Share | 0.32 |
| Working Capital | 112.67M |
Cash Flow
In the last 12 months, operating cash flow was -$49.07 million and capital expenditures -$45,000, giving a free cash flow of -$49.12 million.
| Operating Cash Flow | -49.07M |
| Capital Expenditures | -45,000 |
| Free Cash Flow | -49.12M |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MNMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | -26.17% |
| FCF Yield | -13.30% |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.38% |
| Shareholder Yield | -8.38% |
Analyst Forecast
The average price target for MNMD is $5.48, which is 526.79% higher than the current price. The consensus rating is "Buy".
| Price Target | $5.48 |
| Price Target Difference | 526.79% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
Stock Splits
The last stock split was on February 28, 2020. It was a reverse split with a ratio of 1:8.
| Last Split Date | Feb 28, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:8 |